Suppr超能文献

应用免疫组织化学方法研究子宫颈中肾增生及中肾腺癌的组织发生学起源。

The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods.

作者信息

Lang G, Dallenbach-Hellweg G

机构信息

Institut für Pathologie, Mannheim, F.R.G.

出版信息

Int J Gynecol Pathol. 1990;9(2):145-57. doi: 10.1097/00004347-199004000-00006.

Abstract

Forty-four cases of mesonephric hyperplasia (MH) and two adenocarcinomas arising from mesonephric remnants (MA) in the cervix were compared immunohistochemically with 10 embryonic and fetal mesonephric tissues. The mesonephric cells retained their pattern for intermediate filaments during ontogenesis, as well as in the mature, hyperplastic, and neoplastic states: they expressed cytokeratin 8, cytokeratin 13, and vimentin, the two latter in variable amounts. In embryonic mesonephric tissues, cytokeratin was absent, whereas the staining for vimentin was intense. Fetal mesonephric cells stained for cytokeratin 13 and vimentin, but that staining diminished as maturation progressed. All MH and MA expressed cytokeratin 8, whereas only 20-30% of the cells in MH and 10-20% of carcinomatous mesonephric cells showed positive reactions with anti-cytokeratin 13 and anti-vimentin. CEA was always negative in cells of mesonephric origin. We regard these results to be important, since the reactions with anti-CEA and anti-vimentin enable one to distinguish cervical adenocarcinomas of mesonephric origin from those of endocervical origin, the latter being CEA-positive and vimentin-negative. Clinical studies revealed that approximately 75% of the patients with MH had used oral contraceptives for several years, 46% had precancerous lesions of the cervix, and in 62% the cervical mucosa showed adenomatous microglandular hyperplasia. We believe that hyperplasia of mesonephric remnants in the cervix may occur more often in patients with disturbed hormonal balance. However, the lack of a control population does not enable us to advance this hypothesis with assurance.

摘要

对44例中肾增生(MH)和2例源自宫颈中肾残余的腺癌(MA)进行了免疫组织化学研究,并与10例胚胎和胎儿中肾组织进行了比较。中肾细胞在个体发育过程中以及在成熟、增生和肿瘤状态下均保持其中间丝的表达模式:它们表达细胞角蛋白8、细胞角蛋白13和波形蛋白,后两者的表达量各不相同。在胚胎中肾组织中,细胞角蛋白缺失,而波形蛋白染色强烈。胎儿中肾细胞对细胞角蛋白13和波形蛋白染色,但随着成熟进程,这种染色逐渐减弱。所有MH和MA均表达细胞角蛋白8,而MH中只有20% - 30%的细胞以及癌性中肾细胞中10% - 20%的细胞对抗细胞角蛋白13和抗波形蛋白呈阳性反应。中肾来源的细胞中癌胚抗原(CEA)始终为阴性。我们认为这些结果很重要,因为抗CEA和抗波形蛋白的反应能够使人们区分中肾来源的宫颈腺癌和宫颈内膜来源的腺癌,后者CEA阳性而波形蛋白阴性。临床研究显示,约75%的MH患者曾使用口服避孕药数年,46%有宫颈癌前病变,62%的宫颈黏膜显示腺瘤性微腺增生。我们认为宫颈中肾残余增生可能在激素平衡紊乱的患者中更常见。然而,由于缺乏对照人群,我们无法肯定地推进这一假设。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验